Preferred Label : quizartinib;

MeSH note : an FLT3 inhibitor; structure in first source;

CISMeF synonym : AC220 compound;

Is substance : O;

UNII : 7LA4O6Q0D3;

InChIKey : CVWXJKQAOSCOAB-UHFFFAOYSA-N;

Details


Main resources

You can consult :


https://www.has-sante.fr/jcms/p_3522395/fr/vanflyta-quizartinib-leucemie-aigue-myeloide-lam
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
quizartinib
antineoplastic combined chemotherapy protocols
cytarabine
anthracyclines
adult
FLT3 Internal Tandem Duplication
Acute Myeloid Leukemia with FLT3/ITD Mutation
evaluation of the transparency committee
leukemia, myeloid, acute
quizartinib

---
https://www.ema.europa.eu/en/medicines/human/EPAR/vanflyta-0
2023
false
false
false
Netherlands
French
English
treatment outcome
drug evaluation
quizartinib
quizartinib
quizartinib
FLT3 Internal Tandem Duplication
leukemia, myeloid, acute
adult
administration, oral
orphan drug production
fms-like tyrosine kinase 3
protein kinase inhibitors
protein kinase inhibitors
Tyrosine Kinase Inhibitors
package leaflet
syndication feed
summary of product characteristics
phenylurea compounds
benzothiazoles
phenylurea compounds
benzothiazoles

---
Nous contacter.
01/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.